BAYERCROP
Bayer CropScience
Bayer CropScience (BAYERCROP) Stock Analysis & Case Study
Is BAYERCROP a good buy? The data-driven verdict.
Bayer CropScience (BAYERCROP) trades at ₹4,179,on the numbers it mixed signals, a Downstox Snapshot Score of 49/100.
On the numbers, Bayer CropScience (BAYERCROP) mixed signals, a Downstox Snapshot Score of 49/100, weighing expensive at 381.0× earnings, ROE of 15.8%. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
BAYERCROP fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is BAYERCROP overvalued? BAYERCROP P/E vs its sector
BAYERCROP's P/E of 381.0× sits above the sector peer median of 15.9×, so on earnings it screens richer than peers, while its 2.99% dividend yield is above the peer median of 1.67%.
The bull case for BAYERCROP
- A healthy 15.8% return on equity.
- Strong ROCE (20.1%) shows the core business earns well above its cost of capital.
- Pays a 3.0% dividend yield, so you're partly paid to wait.
The bear case & risks
- A rich 381.0× P/E leaves a thin margin of safety if growth slows.
- A steep 49.5× price-to-book means most of the value is intangible/expectations, not assets on the books.
BAYERCROP Piotroski F-Score: 4/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. BAYERCROP scores 4/9,mixed financial health.
BAYERCROP MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy BAYERCROP with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| UpstoxCHEAPEST | 27.7% | 3.6× |
| ZerodhaCHEAPEST | 27.7% | 3.6× |
| DhanCHEAPEST | 27.7% | 3.6× |
Compare every broker on the BAYERCROP MTF page.
BAYERCROP vs peers,sector comparison
About Bayer CropScience: sector, index & market-cap context
Bayer CropScience (BAYERCROP) is a small-cap NSE-listed company, and a constituent of the Nifty 200 index group, with a market capitalisation of ₹18,747 Cr. See more Nifty 200 stocks.
How the BAYERCROP Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Bayer CropScience's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
BAYERCROP analysis, FAQs
Is Bayer CropScience (BAYERCROP) a good buy?
On the numbers, Bayer CropScience (BAYERCROP) mixed signals, a Downstox Snapshot Score of 49/100, weighing expensive at 381.0× earnings, ROE of 15.8%. This is a data snapshot for research, not investment advice.
Is BAYERCROP overvalued or undervalued?
BAYERCROP trades at 381.0× earnings versus a peer median of 15.9×, so it screens richer than its sector peers.
What is the bull case for BAYERCROP?
A healthy 15.8% return on equity. Strong ROCE (20.1%) shows the core business earns well above its cost of capital. Pays a 3.0% dividend yield, so you're partly paid to wait.
What are the risks in BAYERCROP?
A rich 381.0× P/E leaves a thin margin of safety if growth slows. A steep 49.5× price-to-book means most of the value is intangible/expectations, not assets on the books.